Global Natural Biomaterials Market was valued at US$ 75.07 billion in 2021, according to the Global Natural Biomaterials Market Report, by Product Type (Hyaluronic Acid, Collagen, Gelatin, Fibrin, Cellulose, Chitin/chitosan, Others), by Application (Cardiovascular, Orthopedic, Dental, Plastic Surgery, Wound Healing, Neurology, Neurological Disorders/Central Nervous Systems, Tissue Engineering, Ophthalmology, and Others), and by Region (North America, Latin America, Asia Pacific, Europe, and Middle East & Africa), published by Coherent Market Insights
Global natural biomaterials market was valued at US$ 75.07 Billion in 2021. Natural biomaterials market is expected to register a CAGR of 14.45% over the forecast period (2022–2030), to reach US$ 244.91 Million by 2030.
The natural biomaterials market growth is driven by increasing demand for orthobiologics, escalating usage of natural biomaterials in spine surgeries along with growing orthopedic and cardiovascular surgeries. Furthermore, rising investments in biomaterials field, tremendous growth for plastic surgery, and wound healing applications are expected to boost market growth in the near future. Biomaterials are used for replacing or repairing body tissues and organs Biomaterials are categorized into two main groups: synthetic and natural biomaterials. Synthetic biomaterials are classified as ceramics, metals, biodegradable, and non-biodegradable polymers. Synthetic biomaterials are applied in clinical treatment such as dacron, metal hip, plastic intraocular lens, and other applications. Synthetic biomaterials have few drawbacks including their structure and its composition not being similar to native tissues or organs. Their biocompatibility and ability to induce tissue remodeling is low in comparison with natural biomaterials. Therefore, natural biomaterials play a vital role in replacing tissues and organs and have been attracting scientist’s interest across the globe. Naturally derived biomaterial are derived from biologicals sources such as harvested animal tissues or human donor. Natural Biomaterials has applications in bone regeneration, cardiovascular regeneration, nerve regeneration, and hepatic regeneration.
The COVID-19 pandemic had a significant influence on general hospital treatment globally as well as on the operation of the global economy. The market for orthopedic implants was muted in the short term since many hospitals and clinics remain shuttered due to lockdowns, lowering the need for biomaterials. Consequently, the need for biomaterials has been declined as non-emergent therapies is delayed. The pandemic also significantly influenced many important European nations, including the U.S., Japan, and China. Sales of these products have decreased due to the pandemic and worldwide lockdowns because most of these nations are major producers of biomaterials. The market for biomaterials was consequently slightly harmed.
To know the latest trends and insights prevalent in this market, click the link below:
https://www.coherentmarketinsights.com/market-insight/natural-biomaterials-market-2535
Browse 50 market data tables* and 40 figures* on "Global Natural Biomaterials Market” - Forecast to 2030.
Key Trends and Analysis of the Global Natural Biomaterials Market:
- Among regions, North America accounted for market share of 30.0% in 2021, in the global natural biomaterials market, owing to rising bio-based research, developed healthcare infrastructure, high healthcare expenditure, increasing conferences of biomaterials, and rising prevalence of cardiovascular diseases in the region is expected to boost the demand for natural biomaterials in the near future.
- Natural biomaterials are used for heart valves, bypass grafts, heart transplants, and other cardiovascular treatments. Increasing number of cardiovascular surgeries and heart transplants is generating high demand for natural biomaterials.
- Among product type, collagen is the most frequently used natural biomaterial. Factors such as increasing applications of natural biomaterials in tissue engineering, wound healing, plastic surgery, cardiovascular surgeries, growing number of knee and hip replacement procedures, along with high growth in geriatric population is estimated to propel the demand for natural biomaterials market during the forecast period.
Key Takeaways of the Global Natural Biomaterials Market:
- According to Coherent Market Insights in 2021, among application, cardiovascular segment held largest revenue share of 35% in the global natural biomaterials market in 2021.According to U.S. Healthcare Department in 2020, cardiovascular disease is a leading cause of death in the U.S., resulting in around US$ 300 billion healthcare expenditure annually. The irreversible tissue or organ damage from heart disease creates urgent requirement for novel methods of repair for the heart. Treatments for cardiac diseases ranges from medications to surgical interventions.
- Key players operating in the global natural biomaterials market are focusing on various strategies in order to strengthen their market presence and expand their product portfolio. For instance, in April 2022, Medtronic and GE Healthcare announced a partnership to address the specific needs and demand for treatment in ambulatory surgery centers (ASCs) and office-based laboratories (OBLs). Customers will have access to a comprehensive product portfolio and financial solutions as a result of this new partnership.
